Metastatic malignant teratoma arising from mediastinal nonseminomatous germ cell tumor: a case report.
Primary mediastinal nonseminomatous germ cell tumors (NSGCT) have a worse prognosis than gonadal germ cell tumors (GCTs). Malignant transformation of teratomatous components of GCT to a somatic malignancy is rare. We present a case of primary mediastinal NSGCT with malignant transformation of a teratoma in an active duty airman who presented with a 12-cm anterior mediastinal mass and vertebral body lesion. Pathology confirmed NSGCT with yolk sac and teratomatous components. Chemotherapy for GCT normalized serum tumor markers with little effect on the mediastinal mass. Incomplete resection of the residual tumor revealed high-grade mixed sarcoma. Serum tumor markers rose 3 months following resection with metastatic disease to bone and liver. Chemotherapy targeting sarcoma induced a partial response, but the patient developed acute myeloid leukemia refractory to chemotherapy. We discuss our approach to management of this complicated patient.
Collen
Jacob
J
Walter Reed Army Medical Center, 6900 Georgia Avenue NW, Building 2, Washington, DC 20307, USA.
Carmichael
Mark
M
Wroblewski
Tanya
T
D000328:Adult; D003606:Dacarbazine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D017809:Fatal Outcome; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute; D008297:Male; D008479:Mediastinal Neoplasms / Q000188:drug therapy / Q000473:pathology*; D015080:Mesna / Q000627:therapeutic use; D009373:Neoplasms, Germ Cell and Embryonal / Q000473:pathology; D013724:Teratoma / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*
D003606:Dacarbazine; D004317:Doxorubicin; D015080:Mesna; D007069:Ifosfamide